Robert Casella

机构：AstraZeneca (United States)

发表论文 10 篇 · 总被引 353 次 · h-index 6

代表论文

• Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies (2020 · Journal of Medicinal Chemistry · 被引 111)
• The physicochemical characteristics and bioavailability of indomethacin from β-cyclodextrin, hydroxyethyl-β-cyclodextrin, and hydroxypropyl-β-cyclodextrin complexes (2003 · International Journal of Pharmaceutics · 被引 90)
• Pyrimidinone Nicotinamide Mimetics as Selective Tankyrase and Wnt Pathway Inhibitors Suitable for in Vivo Pharmacology (2015 · ACS Medicinal Chemistry Letters · 被引 66)
• Solid-state β-cyclodextrin complexes containing indomethacin, ammonia and water. I. Formation studies (1998 · International Journal of Pharmaceutics · 被引 35)
• Solid-state β-cyclodextrin complexes containing indomethacin, ammonia and water. II. Solubility studies (1998 · International Journal of Pharmaceutics · 被引 24)
• Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor (2025 · Journal of Medicinal Chemistry · 被引 23)